Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• YC-1 exhibits anti-proliferation, anti-invasion, and anti-metastatic activity in various cancer models.
• The precise mechanisms behind YC-1's anti-invasion and anti-metastatic effects remain largely unelucidated.
• Nasopharyngeal carcinoma (NPC) is an aggressive, highly metastatic head and neck cancer prevalent in Southeast Asia.

Purpose of the Study:

• To investigate the novel anti-invasion mechanisms of YC-1 in NPC.
• To identify specific signaling pathways and proteins modulated by YC-1 in NPC cells.

Main Methods:

• Utilized a functional proteomic platform, reverse phase protein array (RPPA), to analyze protein expression changes.
• Assessed the impact of YC-1 on NPC cell invasiveness and proliferation.
• Investigated the role of specific signaling proteins (EGFR, Src, caveolin, beta-catenin) in mediating YC-1's effects through overexpression studies.

Main Results:

• YC-1 significantly inhibited NPC cell invasiveness and proliferation, inducing PARP cleavage, S-phase arrest, and Chk1/Chk2 activation.
• RPPA analysis revealed YC-1 down-modulated multiple invasion-related proteins (beta-catenin, caveolin, Src, EGFR) and growth-related proteins (AMPKalpha, p-ACC, HER-2, mTOR).
• Overexpression of EGFR, activated Src, or caveolin partially reversed YC-1's anti-invasion effects, while EGFR and activated Src also rescued cells from growth inhibition.

Conclusions:

• YC-1 exerts anti-invasion and anti-proliferation effects in NPC by down-regulating critical signaling proteins including EGFR and Src.
• Identified novel molecular targets and mechanisms underlying YC-1's therapeutic potential in NPC.
• These findings suggest YC-1 could be a promising agent for treating NPC and potentially other metastatic cancers.